ACT Capital Partners, L.P.’s Abivax ABVX Stock Holding History

ACT Capital Partners, L.P.’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.42M	Buy	+85,000	New	+$10.2M	5.47%	6

Other funds holding ABVX

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

ACT Capital Partners, L.P.'s ABVX Position: Q3 2026 in Review

ACT Capital Partners, L.P. opened a new position in Abivax (ABVX) in Q3 2026: 85,000 shares worth $8.42M. The stake represents 5.47% of the portfolio and ranks #6 among its holdings.

94 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

ACT Capital Partners, L.P. held 85,000 shares of Abivax worth $8.42M as of Q3 2026.
Abivax was a new ACT Capital Partners, L.P. position in Q3 2026.
Abivax made up 5.47% of ACT Capital Partners, L.P.'s portfolio in Q3 2026, its #6 holding.
94 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on ACT Capital Partners, L.P.'s 13F filing for Q3 2026, filed 6 Nov 2026.